Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils

Journal of Immunology

Volumn 168, Issue 4, 2002, Pages 1968-1977

  Byrne, Aideen ^a   Reen, Denis J ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0037083341     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.4.1968     Document Type: Article

References (74)

1. Monocytes
2. Tumor necrosis, cachexia, shock, and inflammation: A common mediator
3. Proliferation of a subpopulation of human peripheral blood monocytes in the presence of colony stimulating factors may contribute to the inflammatory process in diseases such as rheumatoid arthritis
4. Septic shock: Pathogenesis
5. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
6. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes
7. Mechanism of endotoxin desensitization: Involvement of interleukin 10 and transforming growth factor β
8. Molecular mechanisms responsible for endotoxin tolerance
9. Bidirectional regulation of macrophage function by TGF-β
10. Regulation of immune responses by TGF-β
11. Immunomodulatory therapies in sepsis
12. The central role of monocytes in the pathogenesis of sepsis: Consequences for immunomonitoring and treatment
13. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: What have we learnt?
14. Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa
15. Chemokine production by human chondrocytes
16. + monocytes in peripheral blood and synovium: Correlation with joint destruction in rheumatoid arthritis
17. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis
18. Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety
19. Corpse clearance defines the meaning of cell death
20. Clearance: The last and often forgotten stage of apoptosis
21. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2
22. 2, and PAF
23. Apoptosis: Phagocytic docking without shocking
24. Molecular mechanism of monocyte predominant infiltration in chronic inflammation: Mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer
25. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages
26. Immunosuppressive effects of apoptotic cells
27. Macrophage phagocytosis of aging neutrophils in inflammation: Programmed cell death in the neutrophil leads to its recognition by macrophages
28. Human neutrophils lose their surface Fcγ RIII and acquire annexin V binding sites during apoptosis in vitro
29. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
30. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis
31. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type 1
32. 3)
33. Human CD14 mediates recognition and phagocytosis of apoptotic cells
34. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-α generation from human peripheral blood monocytes
35. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
36. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance
37. Regulation of macrophage cytokine production by phagocytosis of apoptotic and postapoptotic cells
38. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
39. Immunological monitoring of the inflammatory process: Which variables? When to assess?
40. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent
41. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages
42. Participation of β-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release
43. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α
44. Isoproterenol inhibits 11-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages
45. Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice
46. Current concepts: Immunology: Monocytes and macrophages
47. Systemic inflammatory response syndrome
48. Transforming growth factor β: A matter of life and death
49. Interleukin-10 is upregulated in LPS tolerance
50. Reconciling the concepts of endotoxin sensitization and tolerance
51. Inhibition of lipopolysaccharide-induced in vitro desensitization by interferon-γ
52. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
53. Anti-inflammatory activities of cAMP-elevating agents: Enhancement of IL-10 synthesis and concurrent suppression of TNF production
54. TGF-β: A balancing act
55. Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines
56. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor α production of monocytes
57. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes
58. A receptor for phosphatidylserine-specific clearance of apoptotic cells
59. Is the class A macrophage scavenger receptor (SR-A) multifunctional? The mouse's tale
60. Clq and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocyrosis and uptake of apoptotic cells
61. In vivo administration of GM-CSF promotes the clearance of apoptotic cells: Effects on monocytes and polymorphonuclear leukocytes
62. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of proteases
63. + T lymphocytes in humans
64. Increased susceptibility to apoptosis in circulating lymphocytes of critically ill patients
65. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators
66. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis
67. Bacterial ingestion, tumor necrosis factor-α, and heat induce programmed cell death in activated neutrophils
68. Apoptosis in sepsis: A new target for therapeutic exploration
69. Considering immunomodulatory therapies in the septic patient: Should apoptosis be a potential therapeutic target?
70. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework
71. Clinical aspects: From systemic inflammation to 'immunoparalysis'
72. Uncoupling of inflammatory and destructive mechanisms in arthritis
73. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis
74. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease